Alpine-Bio ApS: Financial statements 2024
CVR: 44607379
Source: annual report 2024, Danish Business Authority
01/02/2024 – 31/12/2024
Alpine-Bio ApS (CVR 44607379) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 94,889 and a net result of DKK -156,738. Equity in the 2024 report amounted to DKK 383,262. The solvency ratio was 19.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 94,889
- Profit/Loss
- DKK -156,738
- Equity
- DKK 383,262
- Total Assets
- DKK 1,989,661
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of February 1, 2024, Søren Anker Nielsen is registered as director of Alpine-Bio ApS.
Alpine-Bio ApS was founded on February 1, 2024.
About Alpine-Bio ApS
Alpine-Bio ApS is a Danish company of the type Anpartsselskab based in Albertslund, founded in 2024. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Søren Anker Nielsen. The company is owned by JUUZ ApS and S21 Holding ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 179,268 and a net result of DKK -61,697 compared with DKK -156,738 the year before. Equity in the 2025 report amounted to DKK 621,565.